A Phase 1 Study of ABBV|319 in People With B|Cell Cancers

A Phase 1 Study of ABBV-319 in People With B-Cell Cancers

Full Title Study M22-716: A First-In-Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy ...

A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug ...

... Patients with Relapsed or Refractory B-Cell Malignancies. Moshe Levy,. Moshe Levy *. 1Baylor University Medical Center, Dallas, TX. Search for ...

ABBV-319: a CD19-targeting glucocorticoid receptor modulator ...

... ABBV-319 in a phase 1 clinical trial. Subjects: Free Research Articles ... 1B), whereas NR3C1 is also expressed across B-cell malignancies.

ABBV-319: a CD19-targeting glucocorticoid receptor modulator ...

Abstract ND01: ABBV-319: A first-in-class Glucocorticoid Receptor ...

A first in-human Phase 1 clinical trial evaluating ABBV-319 in B-cell malignancies (DLBCL, FL, CLL) was recently initiated in late 2022 ...

A Study to Assess the Adverse Events, Change in Disease Activity ...

Description. B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections) ...

Clinical Trials Using Anti-CD19-Glucosteroid Receptor Modulator ...

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Follicular Lymphoma is ...

A Phase I First-in-Human Study of ABBV-011, a Seizure-Related ...

A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer. Clin ...

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation ...

This trial describes outcomes with ABBV-383, an anti B-cell maturation antigen × CD3 bispecific monoclonal antibody in patients with relapsed/refractory ...

Cancer Type - clinical trials search - AbbVie Science

EPCORITAMAB (ABBV-GEN3013). EPCORE NHL-1: A Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.

A Phase 1 Study of ABBV-525 in People With B-Cell Lymphoma

Full Title Study M23-324: A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies Purpose In this study, researchers want to find the ...

Study to Evaluate Adverse Events, Change in Disease Activity, and ...

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies.

AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO ...

New safety and efficacy data from a Phase 1 study (NCT05029882) of ABBV ... Cell Lung Cancer in the Phase II LUMINOSITY Trial. J Clin Oncol ...

A first-in-human study of the potent and highly selective BTK ...

A first-in-human study of the potent and highly selective BTK degrader ABBV-101 in patients with relapsed/refractory B-cell malignancies.

A First In Human Multicenter, Open-Label Study to Determine the ...

... ABBV-319 in B-cell Malignancies. Status: Recruiting. Location: See all (13) locations... Intervention Type: Drug. Study Type: Interventional. Study Phase: ...

1257MO ABBV-400, a c-Met protein-targeting antibody-drug ...

... patients (Pts) with advanced EGFR wildtype (WT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase I study. M. De Miguel. M. De ...

AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with ...

New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, ...

CLINICAL TRIALS - AbbVie Science

EPCORITAMAB (ABBV-GEN3013). EPCORE NHL-1: A Phase 1/2, Open-Label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma.

ABBV-319 / AbbVie - LARVOL DELTA

A first in-human Phase 1 clinical trial evaluating ABBV-319 in B-cell malignancies (DLBCL, FL, CLL) was recently initiated in late 2022 (clinicaltrials.gov, ...

Follicular Lymphoma Clinical Trials - MediFind

Study Type: Interventional. Study Phase: Phase 1. Connect me to this trial. SUMMARY ... Experimental: (ABBV-319) Diffuse Large B-cell Lymphoma (DLBCL) ...